Effective treatment of bipolar disorder, an inherited disease that affects 5.7 million adult Americans, is dependent on maintaining a lithium blood concentration that falls within a narrow range. Current monitoring methods are not amenable to home use by a patient, making it difficult for patients to know when their levels fall outside of this narrow range.
Testing lithium concentration in blood is extremely challenging due to the interference of sodium. ADA's research program will overcome this problem and produce a prototypical device for testing lithium blood concentrations.
"A home-based testing tool will enable patients to monitor their lithium blood concentrations daily and adjust their medication accordingly," said Kent Henry, Ph.D., ADA senior scientist and principal investigator on the project. "Just as home monitoring of blood sugar levels enables diabetics to manage their health, individuals with bipolar disorder will be better equipped to manage their health and overall well-being."
According to the
The project described was supported by Award Number R43MH090779 from the National Institute of Mental Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Metal Health or the National Institutes of Health.
Source
ADA Technologies, Inc.